Form 4: Zevra Therapeutics Director Thomas Anderson Acquires Stock Options

Director Thomas Anderson received stock options for 39,200 shares of Zevra Therapeutics as compensation for board service.

Summary

• On May 13, 2024, Thomas Anderson, a director of Zevra Therapeutics, Inc., was granted stock options to purchase 39,200 shares of the company's common stock.
• The exercise price of these options is $4.89 per share, which was the closing price of ZVRA on the grant date.
• The options were granted as compensation for Anderson's service on the board of directors, according to the company's non-employee director compensation policy.
• The options vest on the earlier of (i) the first anniversary of the grant date, (ii) one day prior to the first annual meeting of stockholders following the grant date, or (iii) immediately prior to a change in control of the Issuer, subject to continued service.

Sentiment

Score: 7

Explanation: The document reflects a routine compensation practice, suggesting stability and alignment of interests. It's a neutral event with a slightly positive implication for corporate governance.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service on the board.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

Stock option grants are a common form of compensation for directors of publicly traded companies, aligning their interests with shareholders.

Comparison to Industry Standards

• Director compensation packages, including stock options, vary widely across the pharmaceutical industry depending on company size, performance, and board responsibilities.
• Comparing Zevra's director compensation to companies like BioCryst Pharmaceuticals or Catalyst Pharmaceuticals would provide a better understanding of whether the compensation is in line with industry standards.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the director to contribute to the company's success.
• Employees may see this as a standard practice for rewarding board members.

Key Dates